Literature DB >> 29890225

Mixomics analysis of breast cancer: Long non-coding RNA linc01561 acts as ceRNA involved in the progression of breast cancer.

Rui Jiang1, Chunming Zhao2, Binbin Gao1, Jiawen Xu3, Wei Song1, Peng Shi4.   

Abstract

OBJECTIVE: This study aimed at finding the long non-coding RNA (lncRNA), miRNA and mRNA which played critical roles in breast cancer (BrCa) by using mixOmics R package.
METHOD: The BrCa dataset were obtained from TCGA and then analyzed using "DESeq2" R package. Multivariate analyses were performed with the "mixOmics" R package and the first component of the stacked partial least-Squares discriminant analysis results were used for searching the interested lncRNA, miRNA and mRNA. qRT-PCR was applied to identify the bioinformatics results in four BrCa cell lines (MCF7, BT-20, ZR-75-1, and MX-1) and the breast epithelial cell line MCF-10 A. Then cells (MCF-1 and MX-1) were transfected with si-linc01561, miR-145-5p mimics and si-MMP11 to further investigate the effects of linc01561, miR-145-5p and MMP11 on the BrCa cells proliferation and apoptosis.
RESULTS: MixOmics results showed that linc01561, miR-145-5p and MMP11 might play important roles in BrCa. qRT-PCR results identified that in BrCa cell lines, linc01561 and MMP11 were higher expressed while miR-145-5p was lower expressed compared with those in epithelial cell line. The linc01561 inhibition elevated miR-145-5p expression and then suppressed MMP11 expression. Moreover, linc01561 inhibition suppressed the BrCa cells proliferation and promoted the apoptosis, which was realized by up-regulating expression of miR-145-5p and down-regulating expression of MMP11.
CONCLUSION: In summary, the findings of this study, based on ceRNA theory, combining the research foundation of miR-145-5p and MMP11, and taking linc01561 as a new study point, provide new insight into molecular-level reversing proliferation and apoptosis of BrCa.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; MMP11; linc01561; miR-145-5p; mixOmics

Mesh:

Substances:

Year:  2018        PMID: 29890225     DOI: 10.1016/j.biocel.2018.06.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516.

Authors:  Zhuo Wang; Ruqing Xu
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

2.  Discriminating Dietary Responses by Combining Transcriptomics and Metabolomics Data in Nutrition Intervention Studies.

Authors:  Kathryn J Burton-Pimentel; Grégory Pimentel; Maria Hughes; Charlotte Cjr Michielsen; Attia Fatima; Nathalie Vionnet; Lydia A Afman; Helen M Roche; Lorraine Brennan; Mark Ibberson; Guy Vergères
Journal:  Mol Nutr Food Res       Date:  2021-01-29       Impact factor: 5.914

3.  HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.

Authors:  Carolyn M Klinge; Kellianne M Piell; Christine Schaner Tooley; Eric C Rouchka
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

4.  LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11.

Authors:  Lin Yang; Hailong Si; Meng Ma; Yu Fang; Yina Jiang; Jintao Wang; Cheng Zhang; Haijuan Xiao
Journal:  Cancer Cell Int       Date:  2021-04-09       Impact factor: 5.722

5.  Regulation of the TUG1/miR-145-5p/SOX2 axis on the migratory and invasive capabilities of melanoma cells.

Authors:  Jiabin Deng; Yinqiu Li; Jiaqian Song; Fei Zhu
Journal:  Exp Ther Med       Date:  2022-07-28       Impact factor: 2.751

6.  Analysis of Competitive Endogenous RNA Regulatory Network of Exosomal Breast Cancer Based on exoRBase.

Authors:  Kangle Zhu; Qingqing Wang; Lian Wang
Journal:  Evol Bioinform Online       Date:  2022-07-20       Impact factor: 2.031

7.  Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.

Authors:  Xing Li; Bing Li; Pixin Ran; Lanying Wang
Journal:  Oncol Lett       Date:  2018-08-21       Impact factor: 2.967

8.  Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.

Authors:  Yangfeng Shi; Yeping Li; Chao Yan; Hua Su; Kejing Ying
Journal:  Oncol Lett       Date:  2019-09-30       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.